20608 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
Modulation of immunity and CEACAM1 activity
#302Materials and Methods for Eliciting Targeted Antibody Responses In Vivo
#303Acellular pro-tolerogenic compositions and process for making same
#304Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
#305COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#306CEACAM1 mediated protective immunity
#307Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor
#308Use of PI3K M-TOR and AKT inhibitors to induce FOXP3 expression and generate regulatory T cells
#309COMPOSITIONS AND METHODS FOR PREVENTING ALLOGENEIC IMMUNE REJECTION
#310METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#311IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT ADULT PROGENITOR CELLS AND USES THEREOF
#312METHODS AND COMPOSITIONS FOR GENERATING AND USING ALLOGENEIC SUPPRESSOR CELLS
#313Compositions and Treatment Methods for Mesenchymal Stem Cell-Induced Immunoregulation
#314Alteration of cell membrane for new functions using IL-2 and streptavidin
#315Treatment for the rapid amelioration of clinical depression
#316COMPOSITIONS FOR TREATING UVEITIS
#317Isolation and use of human lymphoid organ-derived suppressive stromal cells
#318Methods and Compositions Involving Induced Senescent Cells for Cancer Treatment
#319INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
#320IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#321IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#322Anti-TLR4 antibodies and methods of use thereof
#323Glycosphingolipids for use in modulating immune responses
#324Placental stem cell populations
#325METHODS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
#326Methods and compositions for tumor vaccination and therapy
#327Human skin equivalents expressing exogenous polypeptides
#328Method for treating or preventing graft versus host disease
#329Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells
#330Method and compositions for cellular immunotherapy
#331HLA PEPTIDE THERAPY
#332Uses of Growth and Differentiation Factor 8 (GDF-8)
#333HYBRID CELLS FOR TREATING CANCER PATIENTS
#334Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#335Stem cell administration to reduce TNF-α level in CSF of an autism spectrum disorder or pervasive development disorder patient
#336MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
#337IMMUNOMODULATING COMPOSITIONS AND METHODS
#338Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale
#339Method and kit for rapid isolation of human Foxp3+ Treg cells
#340Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#341NF-κB signaling pathway-manipulated dendritic cells
#342Treatment of inflammatory diseases using placental stem cells
#343Modulation of the immune response
#344Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
#345Therapeutic use of neural stem cells
#346Method of treating graft versus host disease
#347Method for treating cancer with an antibody to CD223 protein
#348Methods and compositions for expanding and stabilizing natural regulatory T cells
#349COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS
#350INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS
#351COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES
#352ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY
#353ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES
#354ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#355INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES
#356INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS
#357DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS
#358TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#359THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#360METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#361HYPERBLEBBING SHIGELLA STRAINS
#362Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
#363SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS
#364NEW METHODS FOR ISOLATING TR1 CELLS
#365Placental stem cell populations
#366Placental stem cell populations
#367Peptide analogues
#368Adherent cells from placenta and use of same in disease treatment
#369Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
#370Methods and compositions for use in cellular therapies
#371Regulatory B cells (tBREGS) and their use
#372Stem cell immune modulation methods of use and apparatus
#373METHODS FOR MODULATING BACTERIAL INFECTION
#374CD117+ cells and uses thereof
#375Method for treating chronic lymphocytic leukemia (CC)
#376Methods and compositions for tumor vaccination and therapy
#377Agent and methods for reducing inflammatory markers
#378Enhancement of placental stem cell potency using modulatory RNA molecules
#379Compositions and methods of treating T cell mediated disorder
#380Mesenchymal stem cells expressing TNF-alpha receptors
#381Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
#382Alteration of cell membrane for new functions
#383IMMUNOSUPPRESSING AGENT COMPRISING MESENCHYMAL STEM CELL DERIVED FROM ADIPOSE TISSUE, AND USE THEREOF
#384Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
#385IMMUNOMODULATING COMPOSITIONS COMPRISING INTERLEUKIN 13 INHIBITORS AND USES THEREFOR
#386Anti-TLR4 antibodies and methods of use thereof
#387ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM
#388TREATMENT OF IMMUNE-RELATED DISEASES AND DISORDERS USING AMNION DERIVED ADHERENT CELLS
#389Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#390Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#391Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#392Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction
#393COMPOSITIONS AND METHODS FOR KINASE-MEDIATED CYTOPROTECTION AND ENHANCED CELLULAR ENGRAFTMENT AND PERSISTENCE
#394Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#395FOXP3+ NATURAL KILLER T-CELLS AND THE TREATMENT OF IMMUNE RELATED DISEASES
#396CD4 CD25 T cells and Tr1-like regulatory T cells
#397Human skin equivalents expressing exogenous polypeptides
#398ENHANCED MSC PREPARATIONS
#399NANOPARTICLE-LOADED CELLS
#400In Vitro Generation of Myeloid Derived Suppressor Cells
#401COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#402Methods and compositions for the generation and maintenance of regulatory T cells
#403BIOMARKERS AND USES THEREOF
#404Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
#405COMPOSITIONS AND METHODS FOR GENERATING INTERLEUKIN-35-INDUCED REGULATORY T CELLS
#406Vaccines against tularemia
#407Process for producing a human T-cell population having both cytotoxic and immunosuppressive activities
#408Methods for treating progressive multifocal leukoencephalopathy (PML)
#409MHC-less cells
#410MHC-Less cells
#411MHC-LESS cells
#412MHC- less cells
#413THERAPEUTIC ENCAPSULATED EMBRYONIC STEM CELLS AND MESENCHYMAL STROMAL CELLS
#414USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS
#415Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
#416PLURIPOTENT STEM CELLS, METHOD FOR PREPARATION THEREOF AND USES THEREOF
#417Modulation of Macrophage Activation
#418Method of making an isolated population of FOXP3+ regulatory T cells
#419Methods and compositions for tumor vaccination and therapy
#420TREATMENT OF RHEUMATOID ARTHRITIS USING PLACENTAL STEM CELLS
#421Treatment of psoriasis using placental stem cells
#422USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES
#423Inducible regulatory T-cell generation for hematopoietic transplants
#424CD34 Stem Cell-Related Methods and Compositions
#425COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION
#426Methods and compositions for inhibition of Treg cells
#427IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME
#428Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#429Mesenchymal Stem Cells Expressing TNF-alpha Receptors
#430Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
#431Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
#432IMMUNOPHENOTYPE AND IMMUNOGENICITY OF HUMAN ADIPOSE DERIVED CELLS
#433METHOD FOR PRODUCING GAMMA DELTA T CELL POPULATION
#434METHODS AND COMPOSITIONS FOR MODULATING IMMUNOLOGICAL TOLERANCE
#435ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION
#436Regulatory B cells and their uses
#437Methods of treating inflammatory colon diseases
#438Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy
#439Selective Expansion of Regulatory T Cells
#440METHOD FOR OBTAINING TREG-CELLS
#441Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
#442Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells
#443METHODS OF MODULATING T CELL- DEPENDENT IMMUNE RESPONSES
#444Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#445Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#446EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
#447Rapamycin-resistant T cells and therapeutic uses thereof
#448COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION
#449ACTIVATED MESENCHYMAL STEM CELLS FOR THE PREVENTION AND REPAIR OF INFLAMMATORY STATES
#450Modulation of the Immune Response
#451COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION
#452Expansion Of Renewable Stem Cell Populations
#453Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#454IgE antigenic peptides
#455Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#456Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#457Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells
#458Activated T Cells
#459STRATEGIES TO PREVENT AND/OR TREAT IMMUNIE RESPONSES TO SOLUBLE ALLOFACTORS
#460MESENCHYMAL STEM CELLS AND USES THEREFOR
#461B CELL TOLERANCE INDUCTION
#462REGULATORY T CELLS SUPPRESS AUTOIMMUNITY
#463PEPTIDE ANALOGUES
#464Compositions for treating an intestinal inflammatory condition
#465Placental stem cell populations
#466Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
#467METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#468NOVEL REGULATORY T CELLS AND USES THEREOF
#469Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
#470Human Bone-Forming Cells In The Treatment of Inflammatory Rheumatic Diseases
#471INDUCTION OF IMMUNOLOGICAL TOLERANCE
#472Method for increasing immunoreactivity
#473Treatment methods for autoimmune disorders
#474Isolation and Identification of T Cells
#475METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE
#476T cell immunomodulation by placenta cell preparations
#477Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell
#478HLA peptide therapy
#479METHODS OF SWITCHING THE PHENOTYPE OF T CELLS BY TRANSGENIC LINEAGE FACTOR FOXP3
#480Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
#481Compositions and methods for producing adaptive regulatory T cells
#482Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#483Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof
#484METHOD OF GENERATING REGULATORY T CELLS USING CORD BLOOD AND ADULT BLOOD CD14+ MONOCYTE CELLS
#485Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
#486HUCBC treatment of amyloid associated disease
#487METHOD FOR MODULATING THE IMMUNE RESPONSE BY ACTIVATING OR INACTIVATING THE NOTCH AND/OR STAT4 SIGNAL PATH
#488Embryonic-like stem cells derived from adult human peripheral blood and methods of use
#489METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#490Human skin equivalents expressing exogenous polypeptides
#491Tolerogenic populations of dendritic cells
#492Methods for human allografting
#493Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
#494METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#495RESPIRATORY SYNCYTIAL VIRUS RENDERS DENDRITIC CELLS TOLEROGENIC
#496Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression
#497Hybrid cells for treating cancer patients
#498Tolerogenic dendritic cells, method for their production and uses therof
#499METHOD OF USING STROMA CELLS FROM CORD BLOOD TO EXPAND AND ENGRAFT NUCLEATED CELLS FROM CORD BLOOD
#500Use of PI3K M-TOR and Akt Inhibitors to Induce FOXP3 Expression and Generate Regulatory T Cells
#501Methods of Using Phosphoantigen for the Treatment of Cancer
#502Processes for treating subjects carrying viral infectious agent
#503Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors
#504Genetically modified heart valve xenografts
#505Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale
#506ANTI-CD8 ANTIBODIES BLOCK PRIMING OF CYTOTOXIC EFFECTORS AND LEAD TO GENERATION OF REGULATORY CD8+ T CELLS
#507Human T-cell population
#508Methods For Autologous Stem Cell Transplantation
#509ILT3 and ILT4-related compositions and methods
#510USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION
#511MESENCHYMAL STEM CELLS AND USES THEREFOR
#512Methods and compositions for tumor vaccination and therapy
#513Isolation and Use of Human Regulatory T Cells
#514Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#515USE OF IMMATURE DENDRITIC CELLS TO SILENCE ANTIGEN SPECIFIC CD8+ T CELL FUNCTION
#516Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
#517Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
#518MESENCHYMAL STEM CELLS EXPRESSING TNF-A RECEPTOR
#519COMPOSITIONS CONTAINING SERTOLI CELLS AND MYOID CELLS AND USE THEREOF IN CELLULAR TRANSPLANTS
#520Method of treating graft versus host disease using adipose derived mesenchymal stem cells
#521METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSION
#522METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST
#523METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
#524Generation and isolation of antigen-specific T cells
#525REGULATORY T CELLS AND METHODS OF MAKING AND USING SAME
#526INDUCTION OF REGULATORY T CELL-RESISTANT HELPER CD4+ T CELLS
#527Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
#528METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICES
#529Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#530COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
#531Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
#532Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
#533Obtention of food- or auto-antigen specific TR1 cells from a leukocyte or PBMC population
#534Alteration of cell membrane with FasL
#535Use of cytokines and mitogens to inhibit graft versus host disease
#536Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
#537Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
#538CD34 stem cell-related methods and compositions
#539Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
#540SIRT1 INHIBITION
#541EX-VIVO ISOLATED CD25+CD4+ T CELLS WITH IMMUNOSUPPRESSIVE ACTIVITY AND USES THEREOF
#542Method to Prevent Graft Rejection Using TGF-Beta to Induce T Suppressor Cells
#543INDUCTION OF IMMUNOLOGICAL TOLERANCE
#544Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells
#545Antigen specific immunosuppression by dendritic cell therapy
#546Use Of Umbilical Cord Matrix Cells
#547TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH IL-10 EXPRESSING CELLS
#548TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#549Preparation of regulatory T cells using ICAM-1 co-stimulation
#550MODULATION OF CD200 RECEPTORS
#551Methods for reducing graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells
#552Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
#553Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
#554Treatment of inflammatory diseases using placental stem cells
#555Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
#556Methods for human allografting
#557Stem cell mediated treg activation/expansion for therapeutic immune modulation
#558PRODUCTION OF A BIOLOGICAL FACTOR AND CREATION OF AN IMMUNOLOGICALLY PRIVILEGED ENVIRONMENT USING GENETICALLY ALTERED SERTOLI CELLS
#559Co-transplantation of hepatic stellate cells and islet cells
#560CD127 expression inversely correlates with FoxP3 and suppressive function of CD4Tregs
#561Ablative immunotherapy
#562CEACAM1 mediated protective immunity
#563Tr1 cells for use in atherosclerosis
#564Mesenchymal stem cells and uses therefor
#565Method for preventing, or reducing the severity of, graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells
#566Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
#567Isolation of Stem Cell-Like Cells and Use Thereof
#568DIFFERENT DENDRITIC CELL SUBSETS
#569Placental stem cell populations
#570Tailor-made pluripotent stem cell and use of the same
#571Placental stem cell populations
#572Veto cells effective in preventing graft rejection and devoid of graft versus host potential
#573Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
#574Mesenchymal stem cells expressing TNF-alpha receptors
#575CD4+CD25− T cells and Tr1-like regulatory T cells
#576GENERATION AND ISOLATION OF ANTIGEN-SPECIFIC T CELLS
#577Compositions and methods for inducing chimerism in a subject
#578Surface modification of islet membranes by polymeric grafting methods
#579Dendritic cells pulsed with a bisphosphonate
#580Regulatory CD8cells induced with anti-CD3 antibody
#581Isolated cd4+ t cells defined by cmrf-35
#582Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation
#583Suppression of xenotransplant rejection
#584Cell fusions and methods of making and using the same
#585Stem cells of the islets of langerhans and their use in treating diabetes mellitus
#586Immunophenotype and immunogenicity of human adipose derived cells
#587Modulation of immunity and CEACAM1 activity
#588Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
#589Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#590CEACAM1 based cancer therapy and diagnosis
#591Stem cells of the islets of Langerhans and their use in treating diabetes mellitus
#592Induction of immune tolerance by sertoli cells
#593PRAME peptide analogues
#594Melanoma antigen peptide analogues
#595PSMA peptide analogues
#596Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue
#597Transplant acceptance inducing cells of monocytic origin and their preparation and use
#598Methods of expanding and selecting disease associated T-Cells
#599Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
#600Use of sirnas for gene silencing in antigen presenting cells